Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Heart Failure: An Update.

Pharmaceuticals (Basel) · 2024 · PMC11597711 · PMID 39598331

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Analyses showed a trend for the beneficial effect of Dapagliflozin on worsening SGLT2i was greater in patients with iron deficiency compared to those iron-repleted (HR 0.74 95%CI 0.58–0.92 vs.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.